Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2025 · grant · CPRIT Scholar
Recruitment of Rising Stars
Irfan Asangani · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · fellowship · Hanna Gray Fellow
Amma Asare, MD — HHMI Hanna Gray Fellow (2025-Present)
Amma Asare, Md · The University of Texas MD Anderson Cancer Center · funded by Howard Hughes Medical Institute
2025 · grant · Academic Research
KRAS inhibitor-induced adaptive resistance mechanisms and immune suppression in NSCLC
Don Gibbons · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Benjamin Schrank · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · research · AARF-D
Selective TERT activation to treat APOE4-drived Alzheimer’s disease
Hong Seok Shim · The University of Texas MD Anderson Cancer Center · funded by Alzheimer's Association
2025 · grant · Academic Research
Cancer-Related Fatigue and its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-Exercise Intervention
Michael Roth · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Eric Gardner · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Improving Detection of Hepatocellular Carcinoma in Non-Cirrhotic Metabolic Dysfunction Associated Steatohepatitis (MASLD) Patients
David Fuentes · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025–2027 · training · Diversity Supplement
Proteomic Analysis of Biointegration and Mechanism of Action of Radiopaque, Drug-Eluting, Bioresorbable Vascular Grafts
Allan John Barcena · The University of Texas MD Anderson Cancer Center · funded by American Heart Association
2025 · grant · Academic Research
Preservation of Fertility in Male Cancer Patients Using Pharmacological Approaches
Marie-Claude Hofmann · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
B7-H4 Targeting with Puxitatug Samrotecan (P-Sam) in Recurrent/Metastatic (R/M) Adenoid Cystic Carcinoma (ACC): Efficacy, Safety, and Biomarker Evaluation
Renata Ferrarotto · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Blood based biomarkers to guide clinical decision making with indeterminate pulmonary nodules.
Edwin Ostrin · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Novel tumor suppressive RNA therapeutics for aggressive cancers
George Calin · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Impact of Patient Fitness and Biological Aging on Outcomes for Multiple Myeloma treated with BCMA T-Cell Redirection Therapy
Michelle Hildebrandt · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · LCRF | Boehringer Ingelheim Team Science Award on Innovative Therapeutic Strategies to Understand and Treat Lung Cancers Harboring HER2 Mutations
2025 – LCRF | Boehringer Ingelheim Team Science Award on Innovative Therapeutic Strategies to Understand and Treat Lung Cancers Harboring HER2 Mutations – University of Texas MD Anderson Cancer Center – John Heymach
John Heymach · The University of Texas MD Anderson Cancer Center · funded by Lung Cancer Research Foundation
2025 · grant · Academic Research
Early Clinical Investigator
Chibawanye Ene · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
HSP90 Capacitance: Discovery of a New Mechanism Driving Evolution of Drug Resistance in Head and Neck Squamous Cell Carcinoma
Georgios Karras · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · award
Autophagy inhibition to sensitize medulloblastoma to enhance NK cell immunotherapy
Max Wintermark · The University of Texas MD Anderson Cancer Center · funded by Uncle Kory Foundation
2025 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Luigi Perelli · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Leveraging synthetic and collateral lethality in MTAP loss tumors
Jordi Rodon Ahnert · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025–2027 · award
Listeria weaponizes antitumor immune responses to promote T cell immunity
Benjamin Schrank · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2025 · grant · Academic Research
Development of a shared decision tool to facilitate uptake of the levonorgestrel-releasing intrauterine system for the primary prevention of endometrial cancer
Larissa Meyer · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Prevention
Screening And Vaccination in East Texas (S.A.V.E. TX)
Qian Lu · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Synthetic lethality of TRIP13 and Aurora A in Rb-deficient cancer
Faye M Johnson · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
MALAT1 protects against osteoporosis and bone metastasis
Li Ma · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025–2028 · award
Epigenetic editing to improve melanoma TIL therapy
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by Melanoma Research Alliance
2025 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Rosalie Griffin · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · LCRF Research Grant on Overcoming Resistance in Lung Cancer
2025 – LCRF Research Grant on Overcoming Resistance in Lung Cancer – University of Texas MD Anderson Cancer Center – Ximeng Liu, PhD
Ximeng Liu · The University of Texas MD Anderson Cancer Center · funded by Lung Cancer Research Foundation
2025 · grant · Academic Research
To elucidate the mechanisms and identify therapeutic strategies for radiation-induced leukoencephalopathy in pediatric brain tumor patients
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025–2026 · award
Establishing the Tissue Distribution and Excretion Profile of novel PPARß Agonist S2-11
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2025 · grant · Academic Research
Phase 1 Study of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells for Melanoma Patients with Leptomeningeal Disease
Isabella Glitza · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Clonal hematopoiesis and toxicity from radiation therapy
Kevin Nead · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Rodrigo Romero · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Mechanisms of resistance to tyrosine kinase inhibitors (TKIs) and antibody-drug conjugates (ADCs) in HER2-mutant non-small cell lung cancer (NSCLC)
John V Heymach · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025–2027 · award
Using Cancer Neuroscience approaches to uncover novel targets for malignant peripheral nerve sheath tumors (MPNSTs)
Khalil Ali Ahmad Kasm · The University of Texas MD Anderson Cancer Center · funded by Children's Tumor Foundation
2025 · grant · Academic Research
Exploiting synthetic lethalities between HNRNPK loss and ribosomal dysfunction in del9q AML
Sean Post · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Engineering a microbial-inspired antibody toxin bioconjugate for cancer immunotherapy
Betty Kim · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
AI-based end-to-end radiotherapy planning for breast cancer: Prospective Evaluation and Risk Reduction
Laurence E Court · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025–2027 · award
Decoding Tumor-Associated and Intrinsic Drivers of Cognitive Impairment in NF1 through Integrative Transcriptomics
Rajasekaran Mahalingam · The University of Texas MD Anderson Cancer Center · funded by Children's Tumor Foundation
2025 · grant · Academic Research
Understanding and Overcoming Resistance of SMARCA4 Mutant Lung Cancers to Immunotherapy
Yonathan Lissanu · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
